Phase II Study of Irinotecan (CPT-11) in Children and Adolescents With High Risk Ewing's Sarcoma

Trial Profile

Phase II Study of Irinotecan (CPT-11) in Children and Adolescents With High Risk Ewing's Sarcoma

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Jun 2013

At a glance

  • Drugs Irinotecan (Primary)
  • Indications Ewing's sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Oct 2009 Additional lead trial investigator (Porter L) identified as reported by United Kingdom Clinical Research Network.
    • 10 Oct 2009 New source identified and integrated (United Kingdom Clinical Research Network).
    • 07 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top